Tag: Obesity
-
Wegovy Was Not First to Market: Evolution of GLP-1s
Wegovy arrived on the weight management scene with a clear advantage: it wasn’t the first GLP/GLP-GIP agent, but it raised the bar for efficacy and dosing convenience. This introduction to the market demonstrated that timing and product improvement are critical to success. Our discussion will trace the evolution from Byetta’s and Saxenda’s earlier dosing schedules… Read more
-
Expanding the TPP: Advanced Considerations for Market Access Success
In our previous exploration of the Target Product Profile (TPP), we laid the groundwork for understanding its pivotal role in navigating the complex terrain of market access. But the TPP is not just a static document: it’s a living blueprint that must adapt to the evolving business landscape. In this follow-up post, we expand on… Read more